<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Middle East Afr J Ophthalmol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Middle East Afr J Ophthalmol</journal-id>
      <journal-id journal-id-type="publisher-id">MEAJO</journal-id>
      <journal-title-group>
        <journal-title>Middle East African Journal of Ophthalmology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0974-9233</issn>
      <issn pub-type="epub">0975-1599</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23580861</article-id>
      <article-id pub-id-type="pmc">3617538</article-id>
      <article-id pub-id-type="publisher-id">MEAJO-20-89</article-id>
      <article-id pub-id-type="doi">10.4103/0974-9233.106404</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Delayed Onset Chloroquine Retinopathy Presenting 10 Years after Long-Term Usage of Chloroquine</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kazi</surname>
            <given-names>Mohmmad Salman</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Saurabh</surname>
            <given-names>Kumar</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rishi</surname>
            <given-names>Pukhraj</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rishi</surname>
            <given-names>Ekta</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">Sri Bhagwan Mahavir Vitreoretina Services, Sankara Nethralaya, Chennai, Tamil Nadu, India</aff>
      <author-notes>
        <corresp id="cor1"><bold>Corresponding Author:</bold> Dr. Kumar Saurabh, Associate Consultant, Sankara Nethralaya, 18 College Road, Nungambakkam, Chennai - 600006, Tamil Nadu, India. E-mail: <email xlink:href="vrfellow@gmail.com">vrfellow@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Jan-Mar</season>
        <year>2013</year>
      </pub-date>
      <volume>20</volume>
      <issue>1</issue>
      <fpage>89</fpage>
      <lpage>91</lpage>
      <permissions>
        <copyright-statement>Copyright: &#xA9; Middle East African Journal of Ophthalmology</copyright-statement>
        <copyright-year>2013</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Chloroquine retinopathy is a known complication of long-term use of chloroquine. This retinopathy can appear even after usage of chloroquine has stopped. The present case report describes the history and clinical features of chloroquine retinopathy developing a decade after discontinuing the drug.</p>
      </abstract>
      <kwd-group>
        <kwd>Chloroquine Retinopathy</kwd>
        <kwd>Delayed Onset</kwd>
        <kwd>Drug</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1-1">
      <title>INTRODUCTION</title>
      <p>Chloroquine has been in use for many years for the treatment of malaria and for the long term prophylaxis of inflammatory diseases such as rheumatoid arthritis, lupus erythematous, and Sjogren&#x2019;s syndrome.<xref ref-type="bibr" rid="ref1">1</xref> For the latter indications chloroquine was previously prescribed in dosages of 400&#x2013;600 mg/day but has now been reduced to 250 mg/day.<xref ref-type="bibr" rid="ref2">2</xref><xref ref-type="bibr" rid="ref3">3</xref></p>
      <p>Ocular toxicity associated with chloroquine has been extensively studied since its description in 1957 by Cambaiaggi<xref ref-type="bibr" rid="ref4">4</xref> and in 1959 by Hobbs.<xref ref-type="bibr" rid="ref5">5</xref> It can lead to corneal deposits, lens opacities, and maculopathy causing bull&#x2019;s eye lesion.<xref ref-type="bibr" rid="ref6">6</xref><xref ref-type="bibr" rid="ref7">7</xref> Chloroquine retinopathy (CR) is a severe form of retinal toxicity caused by long-term use of chloroquine with an incidence of 1&#x2013;16%.<xref ref-type="bibr" rid="ref8">8</xref><xref ref-type="bibr" rid="ref9">9</xref> Retinal photoreceptors and retinal pigment epithelium have been postulated as the primary sites of involvement in chloroquine retinopathy.<xref ref-type="bibr" rid="ref9">9</xref> Once established, CR is irreversible and may progress even after cessation of the drug.<xref ref-type="bibr" rid="ref9">9</xref></p>
      <p>In this case report, we present the history and clinical findings of a patient with late onset ocular toxicity, 10 years after stopping chloroquine treatment.</p>
    </sec>
    <sec id="sec1-2">
      <title>CASE REPORT</title>
      <p>A 52-year-old female with Sjogren&#x2019;s syndrome presented to us with diminution of vision in both eyes for 1 year. She was diagnosed 19 years prior to presentation and had been taking chloroquine (250 mg daily) for 7 years. Later, the medication was changed to methotrexate (10 mg/week). The best corrected visual acuities using a Snellen chart were 6/9, N6 and 6/6, N6 in the right and left eye respectively. She could identify 1 plate correctly in the right eye and 10 plates in the left eye using Ishihara&#x2019;s isochromatic plates. Anterior segment examination was within normal limits in both eyes. Indirect ophthalmoscopy of both eyes showed normal looking central fovea with a circular ring shaped area of depigmentation measuring approximately two disk diameters in size akin to a &#x201C;Bull&#x2019;s eye appearance&#x201D;. The rest of the retina and the optic nerve head were within normal limits. Fundus fluorescein angiography showed increased hyperfluorescence due to a window defect in the macular area corresponding to the area of depigmentation and reduced hyperfluorescence due to blockage of choroidal fluorescence in the central fovea [Figures <xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F2">2</xref>]. Spectral domain optical coherence tomography of both eyes showed reduced central foveal thickness (right eye 108 &#x3BC; and left eye 132 &#x3BC;). Both eyes showed generalized loss of outer retinal layers in foveal and parafoveal areas while the left eye showed preservation of the inner segment outer segment (IS- OS) junction [Figures <xref ref-type="fig" rid="F3">3a</xref> and <xref ref-type="fig" rid="F3">b</xref>]. Full-field electroretinogram revealed normal photopic and scotopic responses for both eyes. Multifocal electroretinogram showed reduced central and paracentral ring responses and reduced perifoveal ring responses in both eyes [Figures <xref ref-type="fig" rid="F3">3c</xref> and <xref ref-type="fig" rid="F3">d</xref>]. Based on the history and clinical findings, the patient was diagnosed with late onset chloroquine retinopathy. The patient was informed about the condition and a letter of recommendation addressed to her physician was sent documenting the importance of avoiding chloroquine.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Color fundus photograph showing &#x201C;bulls eye maculopathy&#x201D;</p>
        </caption>
        <graphic xlink:href="MEAJO-20-89-g001"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Fundus fluorescein angiogram showing a ring of increased hyperfluorescence (window defect) surrounding a central area of reduced hyperfluorescence (blocked fluorescence)</p>
        </caption>
        <graphic xlink:href="MEAJO-20-89-g002"/>
      </fig>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>(a) and (b) Optical coherence tomography showing generalized loss of outer retinal layers in parafoveal region in both eyes. (c) and (d) Multifocal electroretinogram showing reduced perifoveal ring responses in both eyes</p>
        </caption>
        <graphic xlink:href="MEAJO-20-89-g003"/>
      </fig>
    </sec>
    <sec sec-type="discussion" id="sec1-3">
      <title>DISCUSSION</title>
      <p>In the present case, the patient had placed on chloroquine on a long-term basis over 10 years prior to presentation and had been under the care of an ophthalmologist thereafter. Her previous records did not reveal any finding suggestive of retinopathy. The onset of chloroquine retinopathy more than a decade after stopping chloroquine emphasizes the need for regular follow-up of patients with a history of long-term chloroquine usage.</p>
      <p>Chloroquine is stored in tissues such as the liver and especially the pigmented uveal ocular tissue.<xref ref-type="bibr" rid="ref10">10</xref> Urinary excretion of chloroquine continues years after cessation of chloroquine.<xref ref-type="bibr" rid="ref10">10</xref> These findings buttress the diagnosis of late onset chloroquine retinopathy in our patient.</p>
      <p>Currently there is no definite treatment for chloroquine retinopathy; hence, it is advisable to discontinue the drug as soon as the signs of toxicity are noted. According to the revised guidelines of the American Academy Of Ophthalmology, each patient who may be placed on long-term chloroquine should undergo a baseline ophthalmic examination which should include both subjective (10&#x2013;2 visual field testing) and objective tests (autofluorescence, multifocal electroretinogram, and spectral domain optical coherence tomography).<xref ref-type="bibr" rid="ref2">2</xref> These tests should be repeated annually if the patient falls in the high risk category for developing chloroquine retinopathy.<xref ref-type="bibr" rid="ref2">2</xref></p>
      <p>The present case report reiterates the need for regular follow-up of patients who have been on chloroquine, even after discontinuation of the treatment. This is important both for the ophthalmologist and the physician to educate the patient about the delayed presentation of this disease entity.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by">
        <p><bold>Source of Support:</bold> Nil</p>
      </fn>
      <fn fn-type="conflict">
        <p><bold>Conflict of Interest:</bold> No.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tehrani</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ostrowski</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Hariman</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Jay</surname>
              <given-names>WM</given-names>
            </name>
          </person-group>
          <article-title>Ocular toxicity of hydroxychloroquine</article-title>
          <source>Semin Ophthalmol</source>
          <year>2008</year>
          <volume>23</volume>
          <fpage>201</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">18432546</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marmor</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Kellner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>TY</given-names>
            </name>
            <name>
              <surname>Lyons</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Mieler</surname>
              <given-names>WF</given-names>
            </name>
          </person-group>
          <article-title>American Academy of Ophthalmology. Revised recommendations on screening for chloroquine and hydroxylchloroquine retinopathy</article-title>
          <source>Ophthalmology</source>
          <year>2011</year>
          <volume>118</volume>
          <fpage>415</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="pmid">21292109</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reed</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Karlinsky</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Delayed onset of chloroquine retinopathy</article-title>
          <source>Can Med Assoc J</source>
          <year>1967</year>
          <volume>97</volume>
          <fpage>1408</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="pmid">6060846</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cambiaggi</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Unusual ocular lesions in acase of systemic lupus erythromatosis</article-title>
          <source>Arch Ophthalmol</source>
          <year>1957</year>
          <volume>57</volume>
          <fpage>451</fpage>
          <lpage>3</lpage>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hobbs</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sorsby</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Freedman</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Retinopathy following chloroquine therapy</article-title>
          <source>Lancet</source>
          <year>1959</year>
          <volume>2</volume>
          <fpage>478</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">14402143</pub-id>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bernstein</surname>
              <given-names>HN</given-names>
            </name>
          </person-group>
          <article-title>Ophthalmologic considerations and testing in patients receiving long term antimalarial therapy</article-title>
          <source>Am J Med</source>
          <year>1983</year>
          <volume>75</volume>
          <fpage>25</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="pmid">6869408</pub-id>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nylander</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Ocular changes in chloroquine therapy</article-title>
          <source>Acta Ophthalmol</source>
          <year>1967</year>
          <volume>92</volume>
          <issue>Suppl</issue>
          <fpage>1</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="pmid">4866642</pub-id>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bertagnolio</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tacconelli</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Camilli</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tumbarelle</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Case report: Retinopathy after malaria prophylaxis with chloroquine</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>2001</year>
          <volume>65</volume>
          <fpage>637</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">11716127</pub-id>
        </element-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sassani</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Brucker</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Cobbs</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Progressive chloroquine retinopathy</article-title>
          <source>Ann Ophthalmol</source>
          <year>1983</year>
          <volume>15</volume>
          <fpage>19</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="pmid">6830093</pub-id>
        </element-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zvaifler</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Rubin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bernstein</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Chloroquine osition</article-title>
          <source>Arthritis Rheum</source>
          <year>1963</year>
          <volume>6</volume>
          <fpage>799</fpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
